55 results
424B3
BXRX
Baudax Bio, Inc.
22 Nov 23
Prospectus supplement
4:58pm
payment in 2022. The third component consisted of three potential payments, based on the achievement of specified annual revenue targets. The fourth
PRER14A
BXRX
Baudax Bio, Inc.
25 Aug 23
Preliminary revised proxy
4:01pm
cells may still bind targets other than the target antigens. If significant unexpected binding or off-target binding occurs in normal tissue, our
424B5
BXRX
Baudax Bio, Inc.
18 Aug 23
Prospectus supplement for primary offering
4:40pm
of forward-looking terminology such as “believes,” “expects,” “may,” “will,” “could,” “should,” “projects,” “plans,” “goal,” “targets,” “potential
DEFA14A
EX-99.2
dgct2ddugz
9 Aug 23
Additional proxy soliciting materials
5:28pm
8-K/A
EX-99.2
1ehmbdpvfyhvpt8
9 Aug 23
Other Events
5:27pm
8-K
EX-99.1
kga8awcrrok
28 Jun 23
Other Events
4:31pm
424B3
b0ir79xj253u5q4k q57
28 Apr 23
Prospectus supplement
4:02pm
424B5
24e6dvno0rl2d kl
19 May 22
Prospectus supplement for primary offering
6:07am